483
Granules Pharmaceuticals Inc.Granules Pharmaceuticals Inc. – FDA 483, Jul 22, 2022
Record Details
Granules Pharmaceuticals Inc. in Chantilly, VA, was inspected and cited for significant deficiencies in its drug manufacturing operations. The inspection revealed failures in quality control unit procedures, non-adherence to production and process control procedures, inadequately designed equipment, and insufficient investigations into major incidents. Additionally, the firm lacked proper procedures to prevent objectionable microorganisms and detailed sanitation methods.
- Person
View Company Profile
ID · 8b164ba2-7c87-4681-bcc0-c7ba8f6d66e7
Other documents for Granules Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.